TrialThe Pediatric infectious disease journal2020

A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants.

Heather L Platt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.